-

Catasys Schedules 2020 First Quarter Financial Results Conference Call for May 7, 2020

SANTA MONICA, Calif.--(BUSINESS WIRE)--Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its first quarter ended March 31, 2020, after the closing of the stock market on Thursday, May 7, 2020.

The Company will also host a conference call/webcast that same day at 4:30 pm ET/1:30 pm PT.

Investors, analysts, employees and the general public are invited to listen to the conference call via:

Conference Call
833-954-1830 (domestic) or 862-298-9413

Webcast
https://event.on24.com/wcc/r/2326353/0F9ABAD5B2C48DE230D39D068B75CFF0

Those who are unable to attend the conference call live can use the following information to hear a replay version:

Conference ID#:

   

3269835

Conference Call Replay:

   

800-585-8367 (domestic) or 404-537-3406 (international)

Expiration Date:

   

5/14/2020

About Catasys, Inc.

Catasys, Inc. is a leading AI and technology-enabled healthcare company whose mission is to help improve the health and save the lives of as many people as possible. Its Catasys PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who aren’t getting the care they need. By combining predictive analytics with human engagement, Catasys delivers improved member health and validated outcomes and savings to healthcare payers.

Catasys’ integrated, technology-enabled OnTrak solution, a critical component of the Catasys PRE platform, is designed to treat members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs.

Catasys has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance.

OnTrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The program improves member health and delivers validated cost savings to healthcare payers of more than 50 percent for enrolled members. OnTrak is available to members of leading national and regional health plans in 30 states and in Washington, D.C.

Learn more at www.catasys.com

Contacts

Brandon LaVerne
blaverne@catasys.com

Catasys, Inc.

NASDAQ:CATS

Release Versions

Contacts

Brandon LaVerne
blaverne@catasys.com

More News From Catasys, Inc.

Ontrak Announces Full Exercise of Overallotment Option in Public Offering of Non-Convertible Preferred Stock

SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that it has closed the full exercise of the underwriters’ over-allotment option regarding its previously announced underwritten public offering of 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock“), resulting in aggregate gross proceeds to the Company of...

Ontrak Announces NASDAQ Global Market Listing

SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that the company’s Common Stock has been listed on the NASDAQ Global Market. Ontrak shares will continue to trade under the ticker “OTRK.” Mr. Terren Peizer, the Company’s Chairman and CEO, stated, “This is another important milestone in our company’s growth trajectory and we are pleased...

Ontrak Announces Closing of Public Offering of Non-Convertible Preferred Stock

SANTA MONICA, Calif.--(BUSINESS WIRE)--Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth enabled, virtualized outpatient healthcare treatment company, today announced that it has closed its previously announced underwritten public offering of 1,700,000 shares of its 9.50% Series A Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock“) at $25.00 per share, for gross proceeds to the Company of $42.5 million. The Company has granted the und...
Back to Newsroom